Literature DB >> 26947387

Successful Recanalization of Native Coronary Chronic Total Occlusion Is Not Associated With Improved Long-Term Survival.

Pil Hyung Lee1, Seung-Whan Lee1, Hee-Soon Park1, Se Hun Kang1, Byeong Joo Bae1, Mineok Chang1, Jae-Hyung Roh1, Sung-Han Yoon1, Jung-Min Ahn1, Duk-Woo Park1, Soo-Jin Kang1, Young-Hak Kim1, Cheol Whan Lee1, Seong-Wook Park1, Seung-Jung Park2.   

Abstract

OBJECTIVES: The purpose of this study was to evaluate long-term clinical outcomes after drug-eluting stent-supported percutaneous coronary intervention (PCI) for native coronary total occlusion (CTO).
BACKGROUND: The benefit of successful recanalization of CTO on prognosis remains uncertain.
METHODS: Between March 2003 and May 2014, 1,173 consecutive patients with CTO of native coronary vessels requiring PCI were enrolled. Drug-eluting stent implantation was performed in all successful procedures (1,004 patients, 85.6%).
RESULTS: During a median follow-up of 4.6 years, the adjusted risks of all-cause mortality (hazard ratio [HR]: 1.04; 95% confidence interval [CI]: 0.53 to 2.04; p = 0.92) and the composite of death or myocardial infarction (HR: 1.05; 95% CI: 0.56 to 1.94; p = 0.89) were found to be comparable between patients with successful and failed CTO-PCI, whereas the adjusted risk of target vessel revascularization (HR: 0.15; 95% CI: 0.10 to 0.25; p < 0.001) and coronary artery bypass grafting (HR: 0.02; 95% CI: 0.006 to 0.06, p < 0.001) was significantly higher in patients with failed CTO-PCI. Among patients (n = 879) in whom complete revascularization for non-CTO vessels was performed, the risk of death or the composite of death or myocardial infarction were not found to differ between patients who underwent successful recanalization of the remaining CTO and patients who did not. This finding was consistent regardless of whether the patient had a multivessel disease including CTO or only had a single CTO disease.
CONCLUSIONS: Successful CTO-PCI compared with failed PCI was not associated with a lesser risk for mortality. However, successful CTO-PCI was associated with significantly less subsequent coronary artery bypass grafting.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chronic total occlusion; drug-eluting stent; percutaneous coronary intervention; prognosis

Mesh:

Year:  2016        PMID: 26947387     DOI: 10.1016/j.jcin.2015.11.016

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  19 in total

1.  Does successful chronic total occlusion recanalization fail to improve long-term survival?

Authors:  Masaki Tanabe
Journal:  Cardiovasc Diagn Ther       Date:  2017-06

Review 2.  Approach to CTO Intervention: Overview of Techniques.

Authors:  Aris Karatasakis; Barbara Anna Danek; Dimitri Karmpaliotis; Khaldoon Alaswad; Minh Vo; Mauro Carlino; Mitul P Patel; Stéphane Rinfret; Emmanouil S Brilakis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-01

3.  Impact of multi-vessel versus single-vessel disease on outcomes after percutaneous coronary interventions for chronic total occlusions.

Authors:  Aurel Toma; Barbara E Stähli; Michael Gick; Cathérine Gebhard; Thomas Nührenberg; Kambis Mashayekhi; Miroslaw Ferenc; Franz-Josef Neumann; Heinz Joachim Buettner
Journal:  Clin Res Cardiol       Date:  2017-02-24       Impact factor: 5.460

Review 4.  Update on the Management of Chronic Total Occlusions in Coronary Artery Disease.

Authors:  Kathleen Kearney; Ravi S Hira; Robert F Riley; Arun Kalyanasundaram; William L Lombardi
Journal:  Curr Atheroscler Rep       Date:  2017-04       Impact factor: 5.113

Review 5.  Expecting the holistic regulation from Chinese medicine based on the "solar system" hypothesis of ischemic heart disease.

Authors:  Jing Luo; An-Lu Wang; Hao Xu; Da-Zhuo Shi; Ke-Ji Chen
Journal:  Chin J Integr Med       Date:  2016-10-26       Impact factor: 1.978

6.  Successful treatment of complex coronary chronic total occlusions improves midterm outcomes.

Authors:  Kai-Ze Wu; Ze-Han Huang; Zhi-An Zhong; Hong-Tao Liao; Yi Zhou; Bing-Zheng Luo; Mahesh Anantha-Narayanan; Rami N Khouzam; Aakash Garg; Vladan Vukcevic; Nicholas G Kounis; Bin Zhang
Journal:  Ann Transl Med       Date:  2019-05

Review 7.  CTO in Contemporary PCI.

Authors:  Mohamed Farag; Mohaned Egred
Journal:  Curr Cardiol Rev       Date:  2022

Review 8.  Does multivessel revascularization fit all patients with STEMI and multivessel coronary artery disease? A systematic review and meta-analysis.

Authors:  Meng-Jin Hu; Xiao-Song Li; Chen Jin; Yue-Jin Yang
Journal:  Int J Cardiol Heart Vasc       Date:  2021-06-11

9.  The Current Status of Percutaneous Coronary Intervention in Korea: Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry.

Authors:  Jae-Sik Jang; Kyoo-Rok Han; Keon-Woong Moon; Dong Woon Jeon; Dong-Ho Shin; Jung-Sun Kim; Duk-Woo Park; Hyun-Jae Kang; Juhan Kim; Jang-Whan Bae; Seung-Ho Hur; Byung Ok Kim; Donghoon Choi; Hyeon-Cheol Gwon; Hyo-Soo Kim
Journal:  Korean Circ J       Date:  2017-05-25       Impact factor: 3.243

10.  Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Chronic Total Coronary Occlusion With Well-Developed Collaterals.

Authors:  Se Yeon Choi; Byoung Geol Choi; Seung-Woon Rha; Man Jong Baek; Yang Gi Ryu; Yoonjee Park; Jae Kyeong Byun; Minsuk Shim; Hu Li; Ahmed Mashaly; Won Young Jang; Woohyeun Kim; Jah Yeon Choi; Eun Jin Park; Jin Oh Na; Cheol Ung Choi; Hong Euy Lim; Eung Ju Kim; Chang Gyu Park; Hong Seog Seo; Dong Joo Oh
Journal:  J Am Heart Assoc       Date:  2017-09-13       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.